Literature DB >> 12611636

Designing of 'intelligent' liposomes for efficient delivery of drugs.

Manuela Voinea1, Maya Simionescu.   

Abstract

The liposome- vesicles made by a double phospholipid layers which may encapsulate aqueous solutions- have been introduced as drug delivery vehicles due to their structural flexibility in size, composition and bilayer fluidity as well as their ability to incorporate a large variety of both hydrophilic and hydrophobic compounds. With time the liposome formulations have been perfected so as to serve certain purposes and this lead to the design of "intelligent" liposomes which can stand specifically induced modifications of the bilayers or can be surfaced with different ligands that guide them to the specific target sites. We present here a brief overview of the current strategies in the design of liposomes as drug delivery carriers and the medical applications of liposomes in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12611636      PMCID: PMC6741336          DOI: 10.1111/j.1582-4934.2002.tb00450.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  27 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 2.  Getting into the brain: approaches to enhance brain drug delivery.

Authors:  Mayur M Patel; Bhoomika R Goyal; Shraddha V Bhadada; Jay S Bhatt; Avani F Amin
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

3.  PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin.

Authors:  Krishna Muppidi; Jeffrey Wang; Guru Betageri; Andrew S Pumerantz
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

Review 4.  Liposomes in tissue engineering and regenerative medicine.

Authors:  Nelson Monteiro; Albino Martins; Rui L Reis; Nuno M Neves
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

Review 5.  Theranostic small interfering RNA nanoparticles in cancer precision nanomedicine.

Authors:  Zhihang Chen; Balaji Krishnamachary; Jesus Pachecho-Torres; Marie-France Penet; Zaver M Bhujwalla
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-10-23

6.  Synthetic liposomes are protective from bleomycin-induced lung toxicity.

Authors:  William M Gwinn; Mayanga C Kapita; Ping M Wang; Mark F Cesta; William J Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-20       Impact factor: 5.464

7.  DNA nanotubes as combinatorial vehicles for cellular delivery.

Authors:  SeungHyeon Ko; Haipeng Liu; Yi Chen; Chengde Mao
Journal:  Biomacromolecules       Date:  2008-09-27       Impact factor: 6.988

8.  Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes.

Authors:  Heather R Bender; Sarah Kane; Mark D Zabel
Journal:  J Vis Exp       Date:  2016-07-23       Impact factor: 1.355

Review 9.  Current trends in the use of liposomes for tumor targeting.

Authors:  Pranali P Deshpande; Swati Biswas; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2013-09       Impact factor: 5.307

Review 10.  CNS delivery via adsorptive transcytosis.

Authors:  Françoise Hervé; Nicolae Ghinea; Jean-Michel Scherrmann
Journal:  AAPS J       Date:  2008-08-26       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.